Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Non-Myeloablative BMT for Sickle Cell Anemia
NCT00489281Phase 2Terminated
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center
- Start
- Jun 2008
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cyclophosphamide in sickle cell anemia (SCA), hemoglobinopathies, sponsored by Sidney Kimmel Comprehensive Cancer Center. Started Jun 2008; status: terminated.
02
Drugs
cyclophosphamide
03
Conditions
sickle cell anemia (SCA)hemoglobinopathies
Beyond the preview
Go deeper on NCT00489281.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00489281.